| 1331636 | COPD13_H | Chronic obstructive pulmonary disease QTL 13 (human) | 1.56 | | Chronic airflow obstruction | post-BD FEV1 minus pre-BD FEV1 | 4 | 57681817 | 183160300 | Human |
| 2289563 | BW441_H | Body weight QTL 441 (human) | 2.66 | .0005 | Body weight | BMI | 4 | 99434973 | 185151317 | Human |
| 1559222 | SAPOA2_H | Serum apolipoprotein A level QTL 2 (human) | 2.35 | | Apolipoprotein level | apolipoprotein A-II level | 4 | 108376545 | 190440336 | Human |
| 1559360 | BW79_H | Body weight QTL 79 (human) | 1.89 | .005 | Body weight | body mass index | 4 | 145336879 | 171336879 | Human |
| 2292886 | MYI20_H | Myocardial infarction susceptibility QTL 20 (human) | | | Myocardial infarction susceptibility | early-onset | 4 | 145336879 | 171336879 | Human |
| 2292901 | MYI21_H | Myocardial infarction susceptibility QTL 21 (human) | | | Myocardial infarction susceptibility | early-onset | 4 | 145336879 | 171336879 | Human |
| 2314741 | GLUCO78_H | Glucose level QTL 78 (human) | .66 | .01 | Glucose level | non-insulin dependent | 4 | 145353344 | 171353344 | Human |
| 1358214 | AASTH29_H | Allergic/Atopic asthma related QTL 29 (human) | 2.12 | | Serum IgE titer | reversible airflow obstruction | 4 | 150391020 | 176391020 | Human |
| 1643324 | BW224_H | Body weight QTL 224 (human) | 1.37 | | Body weight | body mass index | 4 | 155716449 | 181716449 | Human |
| 2300246 | PRSTS355_H | Prostate tumor susceptibility QTL 355 (human) | | .015 | Prostate tumor susceptibility | | 4 | 155716449 | 181716449 | Human |